Clinical Trials Update: Oct. 8, 2002
Osteoporosis Sepsis and Septicemia Depression (Treatment-Resistant)
Here are the latest clinical trials, courtesy of CenterWatch.
Research study for the combined use of study drug and a marketed SERM (Selective Estrogen Receptor Modulator) in postmenopausal women 55-80 years of age with osteoporosis. Sites throughout the USA.
-----Sepsis and Septicemia
Research study to evaluate the efficacy and safety of Drotrecogin Alfa (Activated) in adult patients with Early Stage Severe Sepsis. To be included in this study you must: be an adult with severe sepsis, have presence of a suspected or proven infection and one or more sepsis-associated organ failure. Sites throughout the world.
A research study to evaluate the efficacy and safety of an investigational drug in patients 18 to 85 years old with treatment-resistant depression. Sites throughout the USA.
Copyright 2002 Centerwatch. All rights reserved.